Personal Info
- Country of residence: Jordan
Information
CURRICULUM VITAE
YACOUB IRSHAID
MD, PhD, ABCP Diplomate
BIOGRAPHICAL
NAME: YACOUB M. IRSHAID
BIRTH DATE: August 10, 1954 BIRTH PLACE: Seir
MARITAL STATUS: Married
CITIZENSHIP: Jordanian
HOME ADDRESS: P. O. Box 928295 / Amman 11190 / Jordan
HOME PHONE: +962 6 5166647
MOBILE: + 962 777 818284
HOME FAX:
Email: yacoub.irshaid@yahoo.com, y.irshaid@ju.edu.jo &
y.irshaid@gmail.com
BUSINESS ADDRESS:
Department of Pharmacology
Faculty of Medicine
University of Jordan
Amman 11942
Jordan
BUSINESS PHONE: + 962 6 5355000 Ext. 23430
BUSINESS FAX: + 962 6 5300820
EDUCATION AND TRAINING
UNDERGRADUATE:
Dates Attended: 1972-1980 (Including Premed.)
Name and Location of Institution: University of Jordan, Faculty of Medicine, Amman,
Jordan
Degree Received And Year: M. B., B. S. (MD), 1980.
Major Subject: Medicine & Surgery
GRADUATE:
Dates Attended: 1982-1986.
Name of Institution and Location: Department of Pharmacology, University of Iowa, Iowa
City, Iowa, USA
Degree Received And Year: PhD, 1986.
Major Subject: Pharmacology.
TRAINING:
Dates Attended: Sep. 16, 1992 - Aug 15,1993
Name Of Institution And Location: Center for Clinical Pharmacology
University of Pittsburgh
Medical Center Pittsburgh,
PA, USA.
Program: Clinical Pharmacology.
Credentialed in “Applied Pharmacololgy”
by The "American Board of Clinical Pharmacology" on July, 1994.
APPOINTMENTS AND POSITIONS
ACADEMIC:
1. Professor of Pharmacology, Department of Pharmacology, Faculty of
Medicine, University of Jordan , Amman, Jordan.
September 18, 2005 To Present.
2. Professor of Pharmacology, Department of Clinical Pharmacology, College of
Medicine, King Khalid University, P. O. Box 641, Abha, Kingdom of Saudi
Arabia.
August 28, 1999 to August 21, 2005.
3. Professor of Pharmacology, Department of Pharmacology & Therapeutics,
Faculty of Medicine, Al Quds University, Jerusalem.
February 1, 1997 to August 27, 1999.
4. Professor of Pharmacology, Department of Pharmacology, Faculty of
Medicine, Jordan University of Science & Technology, Irbid, Jordan.
December 1, 1996 To January 31, 1997.
5. Associate Professor of Pharmacology, Department of Pharmacology, Faculty
of Medicine, Jordan University of Science & Technology, Irbid, Jordan.
September 1, 1991 To November 30, 1996.
6. Visiting Research Associate in Medicine, Center for Clinical Pharmacology,
Department of Medicine, University of Pittsburgh Medical Center,
Pittsburgh, PA 15261, USA.
September 16, 1992 To August 15, 1993.
7. Assistant Professor Of Pharmacology, Department of Pharmacology, Faculty
of Medicine, Jordan University Of Science & Technology, Irbid, Jordan.
September 1, 1986 To August 31,1991.
8. Full-Time Lecturer, Dept. Of Pharmacology, Faculty of Medicine, University
of Jordan, Amman, Jordan.
September 8, 1981 To September 15, 1982.
9. Internship Year Training, Jordan University Hospital, Amman, Jordan.
July 1, 1980 To June 30, 1981.
NONACADEMIC (ADMINISTRATIVE):
1. Chairman, Department of Pharmacology, Faculty of Medicine, University of
Jordan , Amman, Jordan.
September 10, 2006 To Present.
2. Assistant Dean, Faculty of Medicine, Al-Quds University, Abu Dies,
Jerusalem.
September 1, 1998 to August 27, 1999.
3. Chairman, Department of Pharmacology & Therapeutics, Faculty of
Medicine, Al Quds University, Abu Dies, Jerusalem.
September 1, 1996 To August 27, 1999.
4. Acting Chairman, Department of Pharmacology, Faculty of Medicine,
Jordan University of Science & Technology.
January 29, 1994 To January 31, 1997.
June 29, 1991 to August 31, 1992.
5. Director, Jordan University of Science and Technology Health Center.
September 15, 1990 To June 28, 1991.
6. Assistant Dean of Student Affairs, Jordan University of Science &
Technology.
September 15, 1989 To September 14, 1990.
CERTIFICATION AND LICENSURE
1. Unrestricted License To Practice Medicine In Jordan, 1981.
2. ECFMG Certificate, 1983.
3. Iowa FLEX (Passed), 1983.
MEMBERSHIP IN PROFESSIONAL, SCIENTIFIC AND OTHER SOCIETIES
1. Jordan Medical Association, Amman, Jordan. July 1981 To Present.
2. Jordanian Alumni Society, Graduates of U. S. Universities and Institutes,
1988 To Present.
3. American Society for Clinical Pharmacology and Therapeutics, USA, July
1993 To 2008.
4. Jordanian Environment Society,
Amman, Jordan. January 16, 1994 To Present.
5. International Association of Therapeutic Drug Monitoring and Clinical
Toxicology (IATDMCT). January 2005 To Present.
6. The Royal Society for the Conservation of Nature – Jordan . 2004 to present
SCHOLARSHIPS:
A 4-Year Scholarship to study for Ph.D in Pharmacology by Yarmouk
University, Jordan, At the University Of Iowa, Iowa City IA, USA. From
August 1982 To August 1986.
ASPET Meeting in Boston.
Distinction:
1. Selected by Medical Students as the “Best Professor” in Basic Medical
Sciences for the Year 2001, at College of Medicine and Medical Sciences,
King Khalid University, Abha, Kingdom of Saudi Arabia.
2. Biographical record of “Who’s Who in Medicine and Healthcare”, Sixth
Edition, 2006-2007.
Other Activities
1. Regional editor of "International Journal of Pharmacology".
2. Reviewer of Research Grants Proposals Submitted for King Abdulaziz
City for Science & Technology (KACST), Riyadh, Saudi Arabia.
3. Review of articles submitted for publication to Saudi Medical Journal
PUBLICATIONS
A. REFEREED ARTICLES:
1. Mitchell D. Green, Yacoub Irshaid and Thomas R. Tephly.
The formation Of N-glucuronides catalyzed by purified hepatic 17β-
hydroxysteroid and 3α-hydroxysteroid UDP-glucuronyltransferases.
In " Advances In Experimental Medicine And Biology", Vol.197:399-405,1986.
2. Yacoub M. Irshaid and Thomas R. Tephly.
Isolation and purification of two human liver UDP-glucuronosyltransferases.
Molecular Pharmacology 31:27-34,1987.
3. Anna Radominska-Pyrek, Piotr Zimniak, Yacoub M. Irshaid, Roger Lester,
Thomas R. Tephly and Jan St.Pyrek.
Glucuronidation of 6α -hydroxy bile acids by human liver microsomes.
Journal Of Clinical Investigation 80:234-241,1987.
4. Mitchell D. Green, Birgit L. Coffman, Yacoub M. Irshaid and Thomas R.
Tephly. Characterization of antibodies to a rabbit hepatic UDPglucuronosyltransferase
and the identification of an immunologically similar
enzyme in human liver.
Archives of Biochemistry and Biophysics 262(1):367-374,1988.
5. T.R. Tephly, B.L. Coffman, C.N. Falany, M.D. Green, Y. Irshaid, J.F. Puig,
S.A. Knapp and J. Baron.
Purification and characterization of mammalian UDPglucuronosyltransferases.
In" Microsomes and Drug Oxidation ". Edited by J. Miners, D. J. Birkett, R.
Drew and M. McManus.(Taylor and Francis), pp263-270,1988.
6. Thomas Tephly, Mitchell Green, Jaime Puig and Yacoub Irshaid.
Endogenous substrates for UDP-glucuronosyltransferases.
Xenobiotica 18(11):1201-1210,1988.
7. Birgit L. Coffman, Thomas R. Tephly, Yacoub M. Irshaid, Mitchell D.
Green, Christine Smith, Michael R. Jackson, Richard Wooster and Brian
Burchell.
Characterization and primary sequence of a human hepatic microsomal
estriol UDP-glucuronosyltransferase.
Archives of Biochemistry and Biophysics 281(1):170-175,1990.
8. Y.M. Irshaid, K.I. Gharaybeh, F.F.Ammari and N.M. Rawashdeh.
Glucuronidation Of 7-hydroxy-4-methylcoumarin by human liver
microsomes. Inhibition by certain drugs.
European Journal Of Drug Metabolism And Pharmacokinetics 15(4):295-
301,1990.
9. Yacoub M. Irshaid, Anna Radominska, Piotr Zimniak, Andrzej Zimniak,
Roger Lester and Thomas R. Tephly.
Glucuronidation of monohydroxylated short chain bile acids by human liver
microsomes and purified human liver UDP-glucuronosyltransferases.
Drug Metabolism and Disposition 19(1):173-177,1991.
10. Yacoub Irshaid and Kamal Gharaybeh.
Glucuronidation of 7-hydroxy-4-methylcoumarin by microsomes from
normal and diseased human livers.
Pharmacology and Toxicology 68:212-214,1991.
11. M. A. Abuirjeie, Y. M. Irshaid, H. F. Al-Hadidi and N. M. Rawashdeh.
Simultaneous high performance liquid chromatographic determination of
dapsone and monoacetyldapsone in human plasma and urine.
Journal of Clinical Pharmacy and Therapeutics 16:247-255,1991.
12. Yacoub M. Irshaid, Hakam F. Al-Hadidi, Mustafa A. Abuirjeie and Nayel M.
Rawashdeh. N-Acetylation phenotyping using dapsone in a Jordanian
population.
British Journal of Clinical Pharmacology 32:289-293,1991.
13. Yacoub Irshaid, Hakam Al-Hadidi, Mustafa Abuirjeie, Ali Latif, Omar
Sartawi and Nayel Rawashdeh.
The acetylator phenotypes of Jordanian diabetics.
European Journal of Clinical Pharmacology 43(6):621-623,1992.
14. Yacoub Irshaid and Mahmood Abu-Khalaf.
Lack of effect of certain histamine H2-receptor blockers on the
glucuronidation of 7-Hydroxy-4-methylcoumarin by human liver
microsomes.
Pharmacology and Toxicology 71:294-296,1992.
15. Y. M. Irshaid, H. F. Al-Hadidi, M. A. Abuirjeie, N. M. Rawashdeh and N. S.
Gharaibeh. Acetylation of dapsone by human whole blood.
International Journal of Clinical Pharmacology, Therapy and Toxicology.
31(1):18-22,1993.
16. Y. M. Irshaid, H. F. Al-Hadidi and N. M. Rawashdeh.
Lack of association between glucose-6-phosphate dehydrogenase deficiency
and dextromethorphan O-demethylation polymorphism.
European Journal of Clinical Pharmacology 44:303-304,1993.
17. Nayel M. Rawashdeh, Hakam F. Al-Hadidi, Yacoub M. Irshaid and Abdel-
Kader H. Battah.
Gastrointestinal dialysis of Digoxin by cholestyramine.
Pharmacology and Toxicology 72:245-248,1993.
18. Y. M. Irshaid, H. F. Al-Hadidi and N. M. Rawashdeh.
Dextromethorphan O-demethylation polymorphism in Jordanians.
European Journal of Clinical Pharmacology 45:271-273,1993.
19. Yacoub Irshaid, Adedayo Adedoyin, Michael Lutze and Robert A. Branch.
Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and
rat liver microsomes.
Drug Metabolism and Disposition 22(1):161-164,1994.
20. Hakam F. Hadidi, Suzanne Cholerton, Sophia C. Monkman, Martin
Armstrong, Yacoub M. Irshaid, Nayel M. Rawashdeh, Ann K. Daly and
Jeffrey R. Idle. Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in
Jordanians.
Pharmacogenetics 4:159-161,1994.
21. H. F. Al-Hadidi, Y. M. Irshaid and N. M. Rawashdeh. Metoprolol α-
hydroxylation is a poor probe for debrizoquine oxidation (CYP2D6)
polymorphism in Jordanians.
European Journal of Clinical Pharmacology. 47:311-314,1994.
22. H. F. Hadidi, S. Cholerton, S. Atkinson, Y. M. Irshaid, N. M. Rawashdeh and
J. R. Idle. The N-oxidation of trimethylamine in a Jordanian population.
British Journal of Clinical Pharmacology. 39:179-181,1995.
23. Y. M. Irshaid, N.M. Rawashdeh, F. Zghoul, I. Jalal and N. M. Najib.
Comparative Pharmacokinetics of 2 brands of cefuroxime following a single
intramuscular injection.
Int. Journal of Clinical Pharmacology and Therapeutics. 33(5):285-293,1995.
24. Hakam F. Hadidi, Yacoub M. Irshaid, Raymond L. Woosley, Jeffrey R.
Idle, and David A. Flockhart. S-Mephenytoin hydroxylation phenotypes in a
Jordanian population.
Clinical Pharmacology & Therapeutics. 58:542-547,1995.
25. Yacoub Irshaid, Robert A. Branch And Adedayo Adedoyin. Metabolic
interactions of putative cytochrome P4503A substrates with alternative
pathways of dapsone metabolism in human liver microsomes.
Drug Metabolism and Disposition. 24(2):164-171, 1996.
26. Y. M. Irshaid, N. M. Rawashdeh, F. F. Awwadi and M. K. Kato.
Comparative pharmacokinetics of two brands of atenolol following a single oral
administration.
Int. Journal of Clinical Pharmacology and Therapeutics. 34(10):457-461,1996.
27. Y. M. Irshaid, H. F. AL-Hadidi, A. Latif, F. Awwadi, M. Al-Zoubi And N. M.
Rawashdeh. Dextromethorphan metabolism in Jordanians: Dissociation of
dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
European Journal of Drug metabolism and Pharmacokinetics. 21(4):301-307,1996.
28. Rawashdeh NM, Battah AH, Irshaid YM, and Al Qato MK. Comparative
pharmacokinetics of two nifedipine products in capsule form following single oral
administration in healthy volunteers.
European Journal of Drug metabolism and Pharmacokinetics. 22(3):259-264,1997.
29. Hadidi H, Irshaid. Y, V°agb′ CB, Brunsvik A, Cholerton S, Zahlsen K, Idle
JR.
Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is
suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
European Journal of Clinical Pharmacology. 54(5):427-441,1998.
30. Yacoub M. Irshaid, Anwar A. Hamdi and Mohammed Al Homrany.
Evaluation of Therapeutic Drug Monitoring of Antiepileptic Drugs.
Int. Journal of Clinical Pharmacology and Therapeutics. 41(3):126-131, 2003.
31. Yacoub M. Irshaid, Anwar A. Hamdi and Mohammed Al Homrany.
Appropriatness of Requests for Therapeutic Drug Monitoring of Antiepileptic
Drugs.
Clinical Laboratory 50(3+4):223-228, 2004.
32. Yacoub M. Irshaid, Mohammed Al Homrany, Anwar A. Hamdi, Keneth K.
Adjepon-Yamoah and Ahmed A. Mahfouz. A Pharmacoepiemiological Study of
Prescription Pattern in Outpatient Clinics of a Teaching Hospital in Southwestern
Saudi Arabia. Saudi Medical Journal 25(12):1864-1870, 2004.
33. Yacoub M. Irshaid, Mohammed Al Homrany, Anwar A. Hamdi, Keneth K.
Adjepon-Yamoah and Ahmed A. Mahfouz. Compliance with the Legal Elements of
Prescriptions in Outpatient Clinics of a Teaching Hospital in Southwestern Saudi
Arabia. Eastern Mediterranean Health Journal 11(5/6):922-928,2005.
34. Mohammed Al-Shehri and Yacoub Irshaid. Snake bites and Scorpion stings in
Children: an audit of cases admitted to Asir Central Hospital, South-western Saudi
Arabia. Middle East Paediatrics 10(1):18-24,2005.
35. Yacoub M. Irshaid, Mohammed A. Al Homrany, and Anwar Hamdi. An
Epidemiological Study of Prescription Pattern for Upper Respiratory Tract
Infections in a Tertiary Health Care Center in Southwestern Saudi Arabia. Saudi
Medical Journal 26(10):447-449,2005.
36. Mohammed A. Al Homrany and Yacoub M. Irshaid. Pharmacoepidemiological
Study of Prescription Pattern of Analgesics, Antipyretics, and Nonsteroidal
Antiinflammatory Drugs at a Tertiary Health Care Center. Saudi Medical
Journal. Vol. 28 (3): 369-374, 2007.
37. Mohammed A. Al-Homrany, Yacoub M. Irshaid, Assem K. El Sherif and Haider A.
Omar. Pharmacokinetics of Gentamicin in Hemodialysis Patients: A Comparative
Study Between Diabetic and Non-diabetic Patients. International Urology and
Nephrolog, 41:663-669, 2009 (Published online September 2008).
38. Ibraheem D. Al-Deeb, Tawfeeq A. Arafat and Yacoub M. Irshaid. The Effect
of Licorice Drink on the Systemic Exposure of Verapamil in Rabbits. Drug
Metabolism Letters. 4:173-179, 2010.
39. Yazun B. Jarrar, Said Ismail, and Yacoub M. Irshaid. N-Acetyltransferase-2
(NAT2) Genotype Frequency Among Jordanian Volunteers. International Journal
of Clinical Pharmacology and Therapeutics, 48 (10):688-694,2010.
40. Eman F. Badran, Abdulqader Shamayleh, and Yacoub M. Irshaid.
Pharmacokinetics of Vancomycin in Neonates Admitted to the Neonatology Unit
at Jordan University Hospital. International Journal of Clinical Pharmacology and
Therapeutics, 49(4):252-257, 2011.
41. Suad M Aqel, Yacoub M Irshaid,Munir N Gharaibeh, and Tawfiq A Arafat. The
Effect of Ethyl Acetate Extract of Pomelo Mix on Systemic Exposure of Verapamil
in Rabbits. Drug Metabolism Letters, 5(2):92-98, 2011.
42. Abdulrahman. M. Ghazi,Abdulazim. S. Salhab, Tawfiq. A. Arafat, and Yacoub. M.
Irshaid. Effect of Mint-drink on Metabolism of Nicotine as Measured by Nicotine
to Cotinine Ratio in Urine of Jordanian Smoking Volunteers. Nicotine and
Tobacco Research. Published online March 31,2011 (doi: 10.1093/ntr/ntr054.
43. Nada A. Yasein, Farihan Barghouti, Fatin T. Al Faris, Lana N. Hatamleh,
Mohammed S. Farah, Yacoub M. Irshaid. Prescription pattern of nonsteroidal
anti-inflammatory drugs in a Family Practice Clinic at Jordan University
Hospital. Jordan Medical Journal, 45(1):9-17,2011.
44. Nada A. Yasein, Farihan Barghouti, Yacoub M. Irshaid , Ahmad A. Suleiman,
Diana Abu-Hassan, Rana Tawil. Elderly patients in Family Practice:
Polypharmacy and Inappropriate Prescribing: Jordan. International Medical
Journal, Accepted, 2011.
45. Muna K. Oqal, Khader N. Mustafa, and Yacoub M. Irshaid. N-Acetyltransferase-2
Genotypes Among Patients With Rheumatoid Arthritis Attending Jordan
University Hospital. Genetic Testing and Molecular Biomarkers, Accepted 2012.
46. Nada A. Yasein, Farihan F. Barghouti, Yacoub M. Irshaid , Ahmad A. Suleiman.
Discrepancies Between Elderly Patient's Self-Reported and Prescribed
Medications: A Social Investigation. Scandinavian Journal of Caring Sciences,
Accepted 2012.
47. Nada A. Yasein, Yacoub M. Irshaid, Farihan F. Barghouti, Wejdan A. Shroukh,
Lana J. Halaseh. Use of antihypertensive medications among elderly patients with
metabolic syndrome attending family practice clinic. International Medical
Journal, Accepted, 2012.
B. PUBLISHED ABSTRACTS:
1. M.D.Green, Y. Irshaid and T.R. Tephly.
Glucuronidation Of α-naphthylamine by rat liver 17β-hydroxysteroid UDPglucuronyltransferase.
Third International Symposium on Biological Reactive Intermediates ( BRI III
) p55,1985.
2. Y.Irshaid and T.R.Tephly.
Isolation of p-nitrophenol UDP-glucuronyltransferase from human liver
microsomes.
The Pharmacologist 27:147,1985.
3. Y.Irshaid, D.D. Nghiem, and T.R. Tephly.
Purification of a human UDP-glucuronosyltransferase.
Federation Proceeding 45:933,1986.
4. A. Radominska-Pyrek, P. Zimniak, Y.M. Irshaid, T.R. Tephly and R. Lester.
Specificity and purification of human hepatic UDP- glucuronyltransferase
acting on monohydroxylated short-chain bile acids.
Hepatology 6(15):1171,1986.
5. A. Radominska-Pyrek, P. Zimniak, Y.M. Irshaid, R. Lester and T.R. Tephly.
Glucuronidation of the 6α-hydroxylated bile acids, hyocholic and
hyodeoxycholic acids, by human liver microsomes.
Hepatology 6(15):1171,1986.
6. Y. Irshaid, T. Hartsell, A. Adedoyin and R. A. Branch.
Monoacetyldapsone inhibition of dapsone N-hydroxylation.
The Pharmacologist 35(3):205,1993.
7. Y. Irshaid, A. Adedoyin and R. A. Branch. Metabolic interactions between
Cytochrome P4503A substrates.
Clinical Pharmacology and Therapeutics 55(2):139,1994.
8. Y. M. Irshaid, M. Al-Homrany, Assem K El Sherif and Haider Omar. Pharmacokinetics of
gentamicin in patients with end-stage renal disease undergoing conventional
intermittent hemodialysis: A comparative study between diabetic and nondiabetic
patients. Ther Drug Monit 29(4):533,2007.
9. Jaber M. Jaber, MS Shomaf, Abdulazim S. Salhab, and Yacoub M. Irshaid. The effects of
meloxicam on the fertility of male rats. J Clin Pharmacol;48:1104,2008.
10. Abdulrahman Ghazi, Abdulazim Salhab, Yacoub Irshaid. Effect of mint drink on
metabolism of nicotine as judged by nicotine to cotinine ratio in urine of smoking
Jordanian volunteers. Ther Drug Monit 31(5):623,2009.
11. Yacoub Irshaid, Iman Badran, Abdulqader Shamayleh. Pharmacokinetics of vancomycin
in neonates admitted to the Neonatology Unit at Jordan university Hospital. Ther Drug
Monit 31(5):652,2009.
12. Irshaid YM, Oukal MK, Mustafa KN. N-Acetyltransferase-2 genotypes among Jordanian
patients with rheumatoid arthritis attending Jordan University Hospital Rheumatology
Clinic. Ther Drug Monit 33(4):505,2011.
13. Irshaid YM, Elawy AM, Ismail SI. Thiopurine S-methylltransferase (TPMT) gene
polymorphism in healthy Jordanian volunteers. Ther Drug Monit 33(4):506,2011.
C. MASTER SETHESIS SUPERVISION:
1. The effects of meloxicam on the fertility of male rats. Co-advisor with Prof.
Abdulazim Salhab, (Student: Jaber Mohammad Yousef Jaber), defended and passed April
2009.
2. The effect of ethyl acetate extract of Pomelo mix on plasma concentration of
verapamil in Rabbits. (Student: Suad Mahmoud Aqel), defended and passed May 2009.
3. N-Acetyltransferase 2 (NAT2) genotype frequency among unrelated Jordanian
volunteers. (Student: Yazun Bashir Jarrar), defended and passed July 2009.
4. The effect of licorice drink on plasma concentration of the antihypertensive agent,
verapamil, in rabbits. (Student Ibraheem Deeb TawfeeqAl-Deeb), defended and
passed July 2009.
5. Effect of mint drink on metabolism of nicotine as measured by nicotine to cotinine
ratio in urine of Jordanian smoking volunteers. (Student Abdulrahman Mahmoud
Abdulqader Ghazi), defended and passed November, 2009.
6. Thiopurine S-methytransferase (TPMT) gene Polymorphisms in healthy Jordanian
volunteers. (Student Asma Mohammad Elawy), defended and passed April 2010.
7. N-Acetyltransferase 2 (NAT2) Genotype FrequencyAmong Patients with
Rheumatoid Arthritis Attending Jordan University Hos[pital Rheumatology Clinic.
(Student: Muna Kamal Abdul-Latif Oqal), defended and passed May 2010.
8. A Study on utilization of antihypertensive drugs in a family practice clinic at Jordan
University Hospital. (Student: Essam Ayed Hammed Al-Ddrabah), defended and
passed June 2010.
9. The potential protective effect of pomegranate (Punica granatum) juice and peel
extract on hepatic toxicity induced by acetaminophen in mice. (Student:Lubna
Abdul Razzaq Al-Sharif), defended and passed August 2010.
10. The association between angiotensin II type 1 receptor gene (AT1R) A1166C variants
and essential hypertension in a sample of the Jordanian population. (Student: Dima
Shahin Ali Shahin), defended and passed January, 2012.
D. MASTER SETHESIS EXAMINATION COMMITTEES (OTHER THAN THE
ABOVE):
1. Chemoprevention of meloxicam, grapefruit juice and the combination of both
against the formation of colonic aberrant crypt foci induced by 1,2-
dimethylhydrazine in rat model. (Student: Naim Jawad Kittana). Defended and
passed May, 2008.
2. Study of the effect of Type 2 diabetes on immortalization of B lymphocytes.
(Student: Manar Saleh Zraikat), Defended and passed August, 2008.
3. The molecular characterization of extended-spectrum beta lactamase-producing
Escherichia coli and Klebsiella species isolates at Jordan University Hospital and
King Hussein Cancer Center (Student: Hala Burhan Al-Qasem), Defended and
passed April 2010.
4.
E. SUBMITTED BIOEQUIVALENCE REPORTS FOR PHARMACEUTICAL
INDUSTRY:
1. A two-way crossover bioequivalency study comparing single doses of
cefuroxime intramuscular injections: Cefuroxime 750 mg, BN 282 (Hikma
Pharmaceuticals, Amman, Jordan) to Zinacef 750 mg, BN B6733GA (Glaxo,
UK).
Prepared by Naji M. Najib, Yacoub M. Irshaid and Nayel Rawashdeh.
Faculty of Pharmacy and Faculty of Medicine, JUST, Irbid, Jordan.
Prepared for Hikma Pharmaceuticals, Amman, Jordan.
2. A two-way crossover bioequivalency study comparing single doses of
nifedipine oral administration: Myogard 10 mg capsules BN 40950 (The
United Pharmaceutical Manufacturing Company, Jordan) to Adalat 10 mg
capsules BN TR931 (Bayer AG, Germany).
Prepared by Nayel M. Rawashdeh, Yacoub M. Irshaid and Mazen K. Qato.
Faculty of Medicine, JUST, Irbid, Jordan and Faculty of Pharmacy, Al-Isra'
University, Amman, Jordan.
Prepared for The United Pharmaceutical Manufacturing Company, Amman,
Jordan.
3. A two-way crossover bioequivalency study comparing single doses of
nifedipine: Myogard 20 Retard 20mg tablets BN 40920 (The United
Pharmaceutical Manufacturing Company, Jordan) to Adalat Retard 20 mg tablets
BN UP071 (Bayer AG, Germany).
Prepared by Yacoub M. Irshaid, Nayel M. Rawashdeh and Mazen K. Qato.
Faculty of Medicine, JUST, Irbid, Jordan and Faculty of Pharmacy, Al-Isra'
University, Amman, Jordan.
Prepared for The United Pharmaceutical Manufacturing Company, Amman,
Jordan.
4. A two-way crossover bioequivalency study comparing single doses of
atenolol: Tenolol 100 mg tablets BN 40534 (The United Pharmaceutical
Manufacturing
Company, Jordan) to Tenormin 100 mg tablets BN 300A (ICI Pharmaceuticals).
Prepared by Mazen K. Qatu, Yacoub M. Irshaid and Nayel M. Rawashdeh.
Faculty of Medicine, JUST, Irbid, Jordan and Faculty of Pharmacy, Al-Isra'
University, Amman, Jordan..
Prepared for The United Pharmaceutical Manufacturing Company, Amman,
Jordan.
PROFESSIONAL ACTIVITIES
TEACHING:
Participated actively in the following courses since 1986.
1. Medical Pharmacology. Drug metabolism, Pharmacokinetics, Receptors and
post receptor phenomena, Pharmacogenetics, Dose-response relationships,
Autonomic nervous system pharmacology, CVS pharmacology & Toxicology
of pesticides, heavy metals, asphyxiants, oxygen, corrosives, mushrooms,
petroleum distillates and snake bites.
2. Pharmacology for Pharmacy Students. Autonomic nervous system
pharmacology, Respiratory pharmacology, GIT pharmacology, & Drugs
used in disorders of coagulation.
3. Pharmacology for Dentistry Students . ANS pharmacology & Endocrine
drugs.
4. Dental Therapeutics . Nonsteroidal antiinflammatory drugs & Antimicrobial
Agents.
5. Pharmacology for Nursing Students 255. ANS pharmacology.
6. Toxicology for Nursing Students. Principles of management of the poisoned
patient, Pesticides, Household products, Corrosives, Heavy metals, Alcohols,
Poisonous mushrooms, Snake bites, Scorpion stings, Asphyxiants and
respiratory irritants, Teratogens, Oxygen toxicity and toxicity of chemical
warfare.
7. Clinical Pharmacology Seminars and Clinical Toxicololgy Lectures for 4th
and 6th year Medical students.
8. Medical Pharmacology: 8 Credits / Whole course/ Faculty of Medicine/ Al
Quds University.
9. Clinical Pharmacology: 2 Credits / Whole course/ Faculty of Medicine/ Al
Quds University.
10. Pharmacokinetics: 3 Credits / Whole course/ Faculty of Pharmacy/ Al Najah
University/ Nablus.
11. Pharmacology: 6 Credits / Whole Course / Faculty of Pharmacy / Al Najah
University/ Nablus.
12. Basic and Clinical Pharmacology, College of Medicine & Medical Sciences,
King Khalid University, Abha, Saudi Arabia
13. Clinical Pharmacology (as part of Internal Medicine), College of Medicine &
Medical Sciences, King Khalid University, Abha, Saudi Arabia
14. Toxicology (as part of Forensic Medicine), College of Medicine & Medical
Sciences, King Khalid University, Abha, Saudi Arabia.
15. Pharmacology 1, College of Pharmacy, King Khalid University, Abha, Saudi
Arabia.
16. Medical Terminolgy, College of Pharmacy, King Khalid University, Abha,
Saudi Arabia.
17. Pharmacokinetics, Postgraduate program in pharmacology, Department of
Pharmacology, Faculty of Medicine, University of Jordan, Amman, Jordan.
18. Medical Pharmacology for medical and dentistry students, Department of
Pharmacology, Faculty of Medicine, University of Jordan, Amman, Jordan.
19. Pharmacoepidemiology, Postgraduate program in pharmacology,
Department of Pharmacology, Faculty of Medicine, University of Jordan,
Amman, Jordan.
20. Organ-system courses (pharmacology part), 2nd & 3rd Medical students,
Department of Pharmacology, Faculty of Medicine, University of Jordan,
Amman, Jordan.
SERVICE:
1. Therapeutic drug Monitoring and Pharmacology & Toxicology
Consultations, College of Medicine & Medical Sciences, King Khalid
University, and Asir Central Hospital, Ministry of Health, Abha Saudi
Arabia. August 28, 1999 to August 21, 2005.
2. Director and Founder of "Clinical Pharmacololgy Unit" (Drug and Poison
Information and Therapeutic Drug Monitoring Unit), Princess Basma
Teaching Hospital, Ministry of Health and Jordan University of Science &
Technology, Irbid, Jordan. April 1, 1995 To August 31, 1996.
RESEARCH INTEREST
1. Characterization and Regulation of Human Liver UDPglucuronyltransferases.
1. Pharmacogenetics: Acetylation & Oxidation Polymorphism in Jordan.
2. Bioavailability and Bioequivalence studies.
3. Patterns of Prescription Writing (in a teaching hospital).
4. Therapeutic Drug Monitoring of antiepileptic drugs, Aminoglycosides &
Vancomycin.
5. Pharmacokinetics of Aminoglycosides in Hemodialysis Patients.
6. Pharmacokinetics of Aminoglycosides & Vancomycin in Neonates.
7. Effect of licorice and pomelo on CYP3A4 activity
8. Genotypes of NAT2 and TPMT.
NATIONAL COMMITTEES
1. Medicinal Plants and Natural Products Committee, Jordan Food and
Drug Administration (JFDA), Amman, Jordan, August 1, 2007 to May
31, 2008
2. Clinical Studies Committee, Jordan Food and Drug Administration
(JFDA), Amman, Jordan, June 1, 2008 to present.
3. Committee for registration of new drugs, Jordan Food and Drug
Administration (JFDA), Amman, Jordan, March 2011 to present.
GRANTS
1. A grant for the characterization of human liver UDPglucuronosyltransferases
from Jordan University Of Science & Technology,
Deanship Of Research, 1987.
2. Two grants for the study of Acetylation and Oxidation Polymorphism in
Jordan from Jordan University Of Science & Technology, Deanship Of
Research, 1988 & 1989.
Additional support, 1994.
3. A grant for the study of the effect of orally administered
cholestyramine/colestipol on the systemic clearance of drugs administered
intravenously into the rabbit, From Jordan University of Science and
Technology, Deanship of Research, 1990.
4. A grant to compare the bioavailability of two cefuroxime preperations
following i. m. injection, From Al-Hikma Pharmaceuticals, Amman,
Jordan, 1994.
5. A grant to compare the bioavailability of two nifedipine tablets and two
capsules following oral administration, From The United Pharmaceutical
Manufacturing Company, Amman, Jordan, 1995.
6. A grant to compare the bioavailability of two Atenolol tablets following oral
administration, From The United Pharmaceutical Manufacturing Company,
Amman, Jordan, 1995.
9. A grant to study pharmacokinetic and dosage regimen design of gentamicin
in patients with ESRD undergoing conventional intermittent hemodialysis, a
comparative study between diabetics and nondiabetics. From King
Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia, 2004.
10. A grant to study pharmacokinetics of aminoglycosides & vancomycin from
“Deanship of Research”, University of Jordan, Amman, Jordan, 2006.
11. A grant to study the Effect of licorice and pomelo on CYP3A4 activity from
“Deanship of Research”, University of Jordan, Amman, Jordan, 2006.
PROFESSIONAL AND SCIENTIFIC MEETINGS
1. 1985 ASPET (American Society Of Pharmacology And Experimental
Therapeutics) Meeting. Boston, Massachusetts, USA.
Isolation Of p-Nitrophenol UDP-Glucuronyltransferase from Human Liver
Microsomes.
2. 1986 FASEB ( Federation Of The American Societies Of Experimental
Biology ) Meeting. St.Louis, MO, USA.
Purification of a Human Liver UDP-glucuronosyltransferases.
3. The Fifth Jordanian Medical Conference,1987. Amman, Jordan.
Bile Acid Conjugation With Glucuronic Acid By Human Liver And Purified
Human Liver UDP-Glucuronyltransferases.
4. The First Scientific Day Of The Faculty Of Medicine, Jordan University of
Science and Technology, Irbid, Jordan (May, 1987).
Glucuronidation Of Some Steroid Hormones And Xenobiotics By Human
Liver And Purified Human Liver UDP-Glucuronyltransferases.
12. Invited Speaker: Princes Basma Hospital, Irbid, Jordan. Resident seminars,
Theophylline Toxicity, April, 1987.
6. Invited Speaker: Faculty of Pharmacy Continued Education Seminars.
Classification of Antimicrobial Agents. December,1987.
7. The Fifth Annual Scientific Day Of The Faculty Of Medicine and The
Faculty Of Pharmacy, Jordan University of Science and Technology, Irbid,
Jordan (April, 1991).
N-Acetylation Phenotyping Using Dapsone In A Jordanian Population.
8. Invited Speaker: Department of Pediatrics Seminars, JUST, Faculty of
Medicine. Prostaglandins & Leukotrienes, November, 1991.
9. The Sixth Annual Scientific Day Of The Faculty Of Medicine, Jordan
University Of Science and Technology, Irbid, Jordan (April, 1992).
Dextromethorphan O-demethylation polymorphism in Jordanians.
10. 1993 ASPET (American Society of Pharmacology and Experimental
Therapeutics) Meeting. San Francisco, California.
Monoacetyldapsone Inhibition of Dapsone N-Hydroxylation.
11. 1995 ASCPT (American Society for Clinical Pharmacology and
Therapeutics) Meeting. San Diego, California. 4th Annual Clinical
Pharmacology Review Course.
12. The "First Sientific Day", Faculty of Medicine, Al Quds University, Abu Dies,
Jerusalem, May 17, 1997.
Dextromethorphan metabolism in Jordanians: Dissociation
of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
13. Palestinian Pharmaceutical Conference III. Ramallah, 5-7/8/1998.
Drugs in Pregnancy & Lactation.
14. Manifestations of Substance Abuse and Addiction, Prince Faisal bin Fahad
Training Program
for School Teachers and Advisers, Abha, Saudi Arabia. October 30, 1999.
15. The Sixth Drug Symposium, Asir central Hospital and College of Medicine &
Health Sciences, King Khalid University. Clinical Pharmacokinetics.
February 2, 2000.
16. Symposium on “Therapeutic Drug Monitoring”, Department of Clinical
Pharmacology College of Medicine & Health Sciences, King Khalid
University and Asir Central Hospital. Principles of therapeutic Drug
Monitoring. May 11, 2000.
17. Health Consequences of Substance Abuse and Addiction, Prince Faisal bin
Fahad Training Program for School Teachers and Advisers, Abha, Saudi
Arabia. February 4, 2001.
18. Hepatic and Ocular Toxicity of Antitubercular Drugs. World TB Day, Asir
Hospital TB Unit, Abha, Saudi Arabia, March 29, 2001.
19. Drugs and pregnancy, toxicity and safety. Course on “Medical Problems
During Pregnancy”. Postgraduate and CME Center, College of Medicine and
Asir Hospital, Abha, Saudi Arabia, April 24, 2003.
20. Appropriateness of requests for therapeutic drug monitoring of antiepileptic
drugs. 9th Annual Research Day, Department of Internal Medicine, College
of Medicine and Medical Sciences, King Khalid University, Abha, Saudi
Arabia, May 7, 2003.
21. Polymorphism in drug metabolism: Clinical significance. Invited speaker, 6th
Saudi Pharmaceutical International Conference, Riyadh, Saudi Arabia,
October 7, 2003.
22. Good Prescribing. “10th Drug Symposium”. Postgraduate and CME Center,
College of Medicine, King Khalid University, Abha, Saudi Arabia, April 29,
2004.
23. A Pharmacoepidemiological study of prescription pattern in outpatient
clinics of Aseer Central Hospital. First Annual Scientific Research Day,
College of Medicine, King Khalid University, Abha, Saudi Arabia, May 20,
2004.
24. Y. M. Irshaid, M. Al-Homrany, Assem K El Sherif and Haider Omar.
Pharmacokinetics of gentamicin in patients with end-stage renal disease
undergoing conventional intermittent hemodialysis: A comparative study
between diabetic and nondiabetic patients. 10th Intwernational Congress of
Therapeutic Drug Monitoring and Clinical toxicology, Nice, France, Sep 9-
14,2007.
25. Abdulrahman Ghazi, Abdulazim Salhab, Yacoub Irshaid. Effect of mint
drink on metabolism of nicotine as judged by nicotine to cotinine ratio in
urine of smoking Jordanian volunteers. 11th Intwernational Congress of
Therapeutic Drug Monitoring and Clinical toxicology, Montreal, Canada,
Oct 3-8,2009.
26. Yacoub Irshaid, Iman Badran, Abdulqader Shamayleh. Pharmacokinetics of
vancomycin in neonates admitted to the Neonatology Unit at Jordan
university Hospital. 11th International Congress of Therapeutic Drug
Monitoring and Clinical toxicology, Montreal, Canada, Oct 3-8,2009.
27. Irshaid YM, Oukal MK, Mustafa KN. N-Acetyltransferase-2 genotypes
among Jordanian patients with rheumatoid arthritis attending Jordan
University Hospital Rheumatology Clinic. 12th International Congress of
Therapeutic Drug Monitoring and Clinical toxicology, Stuttgart, Germany,
Oct 2-6,2011.
28. Irshaid YM, Elawy AM, Ismail SI. Thiopurine S-methylltransferase (TPMT)
gene polymorphism in healthy Jordanian volunteers. . 12th International
Congress of Therapeutic Drug Monitoring and Clinical toxicology, Stuttgart,
Germany, Oct 2-6,2011.
WORKSHOPS
1. Health Professionals' Education Workshop On “Assessment and
Evaluation”, 29 August – 3 September 1987, JUST, Faculty Of Medicine,
Irbid, Jordan.
2. University Education Workshop On “Education and Assessment
Technology”, 24-28 August, 1991, JUST, Faculty of Medicine, Irbid,
Jordan.
3. Workshop on Student Assessment. College of Medicine, King Khalid
University, Abha, Saudi Arabia. October 31, 1999.
4. Workshop on Research Methods in Medical Education, College of
Medicine, King Khalid University, Abha, Saudi Arabia. December 5,
1999.
5. Computer and Internet Applications in the Medical Field, College of
Medicine, King Khalid University, Abha, Saudi Arabia. December 11-15,
1999.
6. Statistical Interpretation of Research Data. College of Medicine Research
Center, College of Medicine and Medical Sciences, King Khalid
University, Abha, Saudi Arabia. April 25-26,2001.
7. Clinical Utilization of the Skill Lab. College of Medicine Research Center,
College of Medicine and Medical Sciences, King Khalid University, Abha,
Saudi Arabia. 28 & 30 January, 2002.
8. SPSS Hands on Workshop and Statistical Interpretation of Data in
Clinical Research. College of Medicine Research Center, College of
Medicine and Medical Sciences, King Khalid University, Abha, Saudi
Arabia. 6 June, 2002.
9. Workshop on: Educational Planning and Evaluation. Organized by
“Saudi Council for Health Specialties” in Collaboration with
“Department of Medical Education, College of Physicians & Surgeons of
Pakistan”. Aseer Central Hospital, Abha, Saudi Arabia. October 26-28,
2002.
10. Workshop on: Teaching Skills. Organized by “Saudi Council for Health
Specialties” in Collaboration with “Department of Medical Education,
College of Physicians & Surgeons of Pakistan”. College of Medicine &
Medical Sciences, King Khalid University, Abha, Saudi Arabia. October
29-31, 2002.
11. Workshop on MS PowerPoint. College of Medicine & Medical Sciences,
Computer Laboratory, King Khalid University, Abha, Saudi Arabia.
January 23, 2003.
12. Workshop on Extended Matching Multiple Choice Questions,
Educational Development Center, College of Medicine & Medical
Sciences, King Khalid University, Abha, Saudi Arabia. April 28, 2003.
13. Workshop on Leadership Development Program for Health
Professionals, Center for Educational Development, University of Jordan,
Amman, Jordan, (May, June), 2006
14. “Internal QMS Auditor Training Course”, by “LRQA”, 18-19 April,
2007.
15. The first JAPM Bioequivalence Conference, 14-15 July, 2008, Amman,
Jordan.
16. “Facilitating Clinical Trials in MENA Region” Conference, 23-24
October, Amman, Jordan.
17. “Polymerase Chain Reaction (PCR)”, Center of Consultation, University
of Jordan, February 1st-12th,2009, Amman, Jordan.
18. “Independent Ethics Committees Training”, ClinArt International,
Dubai-UAE, March 6-7,2009.
19. “The Second Conference For Faculty of Medicine at the University of
Jordan, and the 5th Conference for Jordanian Medical Faculties”,
Amman, Jordan 18-20/April/2009. Medical Education in the Third
Millennium, Amman, Jordan.
20. “Expert Training on the Process of Accreditation of Medical Schools”,
Higher Education Accreditation Commission, 1, February, 2010.
21. Workshop on “Clinical Investigation Training Program (CITP I)”, May
8-9, 2010, Amman, Jordan. Trainer on behalf of Jordan FDA.
22. Institutional Review Board (IRB) Manual Training, July 31,2010,
Amman, Jordan, sponsored by JAPM.
23. Good Clinical Practice Workshop, September 20-21,2010, Amman,
Jordan, sponsored by JAPM.
24. Workshop on “Clinical Investigation Training Program (CITP III)”,
April 30, 2011, Amman, Jordan. Trainer on behalf of Jordan FDA.
25. Workshop on “Problem-Based Learning”, April 24, 25, 2011, Faculty of
Medicine, University of Jordan, Amman, Jordan, sponsored by “WHO”.
26. Workshop on “Clinical Investigation Training Program (CITP V)”,
December 17, 2011, Amman, Jordan. Trainer on behalf of Jordan FDA.
27. Workshop on “Clinical Investigation Training Program (CITP VI)”, May
26, 2012, Amman, Jordan. Trainer on behalf of Jordan FDA.
COMMITTEES
1. Research & Continued Medical Education Committee (Faculty Of Medicine
/JUST):
1986/1988; 1995/1996
2. Library Committee ( Faculty Of Medicine /JUST ):
1986/1988.
3. Tender Committee ( Faculty Of Medicine /JUST ):
1986/1987.
1988/1992.
4. Curriculum and Examination Committee ( Faculty Of Medicine /JUST ):
1991/1992.
1993/1996.
5. Pharmacy and Therapeutics Committee ( Faculty Of Medicine /JUST ):
1993/1996.
6. Seminars and Conferences Committee ( Faculty Of Medicine /JUST ):
1994/1995.
7. Research Council (Deanary of Research/JUST):
1995/1996
8. Scientific Days Committee (Faculty of Medicine/Al-Quds University):
1996/1999
9. Library Convenor (Faculty of Medicine/Al-Quds University):
1996/1998
10. Academic Council/Al-Quds University:
1996/1998
11. Promotion Committee/Al-Quds University:
1996/1999
12. Curriculum and Examination Committee (Faculty Of Medicine / Al-Quds
University):
1996/1999
13. Committee of Health Sciences Academic and Research Programs/ Al-Quds
University:
1997/1999
14. Committee of Editors of Al-Quds University Research Journal:
1997/1999
15. Curriculum Committee, College of Medicine & Health Sciences, King Khalid
University, Abha, Saudi Arabia.
1999/2005
16. College of Medicine Research Center (CMRC) Council, King Khalid
University, Abha, Saudi Arabia.
2000/2002
17. Research Committee, College of Medicine and Medical Sciences, King Khalid
University, Abha, Saudi Arabia.
2000/2002
18. Student Advisory Committee, College of Medicine and Medical Sciences,
King Khalid University, Abha, Saudi Arabia.
2001/2005
19. Research Sub-committee (College of Medicine and King Faisal Speciality
Hospital), College of Medicine and Medical Sciences, King Khalid
University, Abha, Saudi Arabia. 2000/2002Committee for Formulating
Guidelines for "Ethics in Medical Research", College of Medicine and
Medical Sciences, King Khalid University, Abha, Saudi Arabia. (Ad hoc),
2001-2002
29. Committee for Preparing Curriculum for College of Pharmacy, College of
Medicine and Medical Sciences, King Khalid University, Abha, Saudi
Arabia.
(Ad hoc), 2001-2002
21. Committee for Foundation and Establishment for College of Pharmacy,
College of Medicine and Medical Sciences, King Khalid University, Abha,
Saudi Arabia.
(Ad hoc), 2002-2003
22. Committee for Foundation of Central Laboratory, College of Medicine and
Medical Sciences, King Khalid University, Abha, Saudi Arabia.
(Ad hoc), 2002-2003
23. Committee for Establishing a Molecular Medicine Course for Medical
students. College of Medicine and Medical Sciences, King Khalid University,
Abha, Saudi Arabia. (Ad hoc), 2005
24. Committee of Postgraduate Studies, Faculty of Medicine, University of
Jordan, Amman, Jordan. 2005/2012.
25. Committee of Postgraduate Studies, Department of Pharmacology, Faculty of
Medicine, University of Jordan, Amman, Jordan.
2005/2012.
26. Curriculum and Examinations committee, Faculty of Medicine, University of
Jordan, Amman, Jordan. 2006/2007, 2010/2011
27. Committee of "Teaching Units" Organizers, Faculty of Medicine, University
of Jordan, Amman, Jordan. 2006/2012.
28. Research Committee, Faculty of Medicine, University of Jordan, Amman,
Jordan. 2007/2012.
29. Jordan University Research Council, 2011/2012.
Achievements and Awards
- Abdul Hameed Shoman Award for Young Arab Scientists, 1994.
- Fulbright Postdoctoral Research Grant 1992/1993.
- Eli Lilly and Company Graduate Student Travel Award for the 1985
- Years in active
: From
To